Navigation Links
The Waxman Foundation announces $25,000 grant in B-cell lymphoma research
Date:8/2/2011

221.10.254.64

NEW YORKScott Hiebert, Ph.D., of Vanderbilt University was awarded a $25,000 grant from the Samuel Waxman Cancer Research Foundation to further his research in abnormal BCL6 overexpression, which occurs in a common B-cell lymphoma.

Hiebert and his colleagues at Vanderbilt University have obtained drugs that inhibit HDAC3another epigenetic control element leading to abnormal gene programs, and ultimately cancer. Scientists believe that by eliminating BCL6, they can turn the genes back on and kill the cancer cells. If the researchers can inhibit HDAC3, they hope to knock out B-cell lymphoma completely.

Hiebert's research will be funded by the National Institutes of Health (NIH) in January 2012. To ensure that his important work continues without interruption, Vanderbilt-Ingram Cancer Center will match the Waxman Foundation's award to help get Hiebert's work started before the start of his NIH grant. The Max Cure Foundation has also agreed to collaborate with the SWCRF in supporting the work.

"The Max Cure Foundation is humbled to be collaborating not only with SWCRF, but also with Vanderbilt-Ingram Cancer Center and NIH in what promises to be significant research in the area of B-cell lymphoma, the cancer that struck my grandson, Maxthe inspiration for our foundation," said Richard Plotkin, the Vice Chairman of the Max Cure Foundation.

"The SWCRF is proud to join forces with such prestigious organizations to support a novel grant that will examine epigenetic therapy for B-cell lymphoma," said Samuel Waxman, M.D., the Founder and Scientific Director of the SWCRF. "Collaboration is the hallmark of the SWCRF, and we are delighted to play a role in not only fostering collaboration among scientists, but in collaborating with funding organizations as well."


'/>"/>

Contact: Jenny Song
jsong@waxmancancer.org
212-867-4502
Samuel Waxman Cancer Research Foundation
Source:Eurekalert

Page: 1

Related medicine news :

1. The Samuel Waxman Cancer Research Foundation awards more than $3.1 million in grants
2. Michael J. Fox Foundation Awards $1 Million to Drive Critical New Research Tools and Technologies in Parkinsons Drug Development
3. Highmark Foundation Awards $120,000 to the American Heart Association
4. Stuttering Foundation Hails New Research
5. Autism Science Foundation Offers IMFAR Grants to Autism Stakeholders
6. Alzheimers Foundation of America Applauds Social Security for Speeding Disability Benefits for Early-Onset Alzheimers Disease
7. Reliv Foundation Donates $450,000 In Nutritional Supplements to Haitian Relief Efforts
8. Kaiser Foundation Health Plan and Hospitals Report Fourth Quarter and Fiscal Year 2009 Financial Results
9. Instaflex Announces Proceeds Agreement with Arthritis Foundation
10. AMERICAN IDOL to Benefit the UN Foundation Fund for Haiti Thursday, February 25, on FOX
11. MEMC Foundation Donates to Help Fight Malnourishment in Haiti
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... ... 01, 2015 , ... The PT Outcomes Registry is an organized system for ... patients. The Registry is being developed by the American Physical Therapy Association (APTA). , ... be selected to contribute FOTO Outcomes measures as one of the primary global outcomes ...
(Date:8/31/2015)... GA (PRWEB) , ... August 31, 2015 , ... Sculpted ... one of Atlanta’s Women of Power and Influence by Modern Luxury’s The Atlantan Magazine. ... for the business as well as Kathy King. Her idea and vision to ...
(Date:8/31/2015)... ... 2015 , ... Dental clinicians from Newcastle University, United Kingdom, ... learn more about its integrated approach to diabetes care. , Philip Preshaw, BDS, ... Medicine at Newcastle University, and Susan Bissett, National Institute for Health Research Clinical ...
(Date:8/31/2015)... ... August 31, 2015 , ... In an article based on a ... addressed the topic of treating back pain caused by a disrupted disk by using ... slightly improve physical function in patients suffering from a herniated disk, the level of ...
(Date:8/31/2015)... ... ... The Lisle family law firm of Momkus McCluskey, LLC is ... to earn a “Leading Lawyers” distinction. , The “Leading Lawyers” distinction ... The nomination process is based on statewide peer survey nominations and the approval of ...
Breaking Medicine News(10 mins):Health News:FOTO Selected as Official Registry Partner with Physical Therapy Outcomes Registry 2Health News:Sculpted Contours Owner Selected One of Atlanta's Women of Power and Influence by Modern Luxury's The Atlantan Magazine 2Health News:Sculpted Contours Owner Selected One of Atlanta's Women of Power and Influence by Modern Luxury's The Atlantan Magazine 3Health News:Western Diabetes Institute Collaborates with UK team 2Health News:Western Diabetes Institute Collaborates with UK team 3Health News:Western Diabetes Institute Collaborates with UK team 4Health News:Article on Steroid Use for Back Pain Highlights the Effectiveness of Surgery in Treating Disk Pain, says Dr. Seyed M. Rezaian 2Health News:DuPage County Family Law Attorney Named Illinois Leading Lawyer 2
... HealthDay Reporter , WEDNESDAY, March 14 (HealthDay News) ... myeloid leukemia, researchers were able to more accurately predict ... remission, and which ones would respond well to standard ... Memorial Sloan-Kettering Cancer Center in New York City analyzed ...
... HealthDay Reporter , WEDNESDAY, March 14 (HealthDay News) -- People ... a genetic predisposition to be overweight, compared to those who ... The findings don,t prove that the exercise is the ... something else could explain why those who walked were thinner, ...
... meditating for years thickens the brain (in a good ... a further report by UCLA researchers suggests yet another ... at the UCLA Laboratory of Neuro Imaging, and colleagues, ... gyrification ("folding" of the cortex, which may allow the ...
... discrimination is enough to depress anyone, but African-American men ... stoicism and emotional control experience more depression symptoms, according ... at Chapel Hill. The study, "Taking It Like ... Racial DiscriminationDepressive Symptoms Association Among African-American Men," was published ...
... millions of molecules in a drop of a patient,s blood ... or a drug ferry that doesn,t release its toxic contents ... nanotechnologies could be game changers in how we diagnose, monitor ... Engineering at the California Institute of Technology, and a member ...
... identify people infected with hepatitis C virus (HCV) ... new report published in Clinical Infectious Diseases ... reducing HCV-related mortality and morbidity, however, will require ... testing but also linking those infected with the ...
Cached Medicine News:Health News:Detailed Gene Scan Might Help Guide Leukemia Treatment 2Health News:Detailed Gene Scan Might Help Guide Leukemia Treatment 3Health News:Detailed Gene Scan Might Help Guide Leukemia Treatment 4Health News:Brisk Daily Walk Could Counter 'Obesity Genes' 2Health News:Evidence builds that meditation strengthens the brain, UCLA researchers say 2Health News:Hiding emotions may exacerbate depression among black men who confront racial discrimination 2Health News:Fighting cancer with nanotechnology 2Health News:Broader screening for hepatitis C would be cost effective, study suggests 2
(Date:8/31/2015)... Aug. 31, 2015  Soligenix, Inc. (OTCQB: ... company developing products that address unmet medical needs ... announced today it has completed enrollment of the ... Committee (DRC) earlier this year, into the company,s ... first-in-class innate defense regulator (IDR) and is being ...
(Date:8/31/2015)... 2015  Asterias Biotherapeutics, Inc. (NYSE MKT: AST), ... of regenerative medicine, today announced that the third ... -based Rush University Medical Center in a ... doses of AST-OPC1 (oligodendrocyte progenitor cells) in newly ... spinal cord injury (SCI). This represents the final ...
(Date:8/31/2015)... N.J. and STAMFORD, Conn. ... pharmaceutical subsidiary of Eisai Co., Ltd., and Purdue Pharma ... worldwide collaboration agreement for the development and commercialization of ... orexin receptor antagonist entering Phase III clinical development for ... terms of the agreement, Eisai and Purdue Pharma will ...
Breaking Medicine Technology:Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 2Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 3Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 4Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 5Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 6Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 2Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 3Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 4Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 5
... , HELSINKI, Dec. 14 Cancer ... with the introduction of RapidArc® radiotherapy technology from Varian Medical ... radiotherapy clinic in the Nordic region. Clinicians at Docrates Clinic ... radiotherapy to treat patients with multiple brain metastases and cancers ...
... , WALTHAM, Mass., Dec. ... authority on medical technology market intelligence, increased use of safety ... be a key driver of the enteral feeding device markets ... and European Markets for Enteral Feeding Devices 2010 report ...
Cached Medicine Technology:Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments 2Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments 3Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014 2Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014 3
... Splint is constructed of a durable heat moldable ... flexor tendons of the hand and fingers from ... in the later stages of the healing process. ... hand and positions the wrist at 30° of ...
Bunell Mini-Modified Safety Finger Pin reduces PIP flexion contractures....
... FoamWrap Finger Trappers are ideal for ... restore finger motion. Finger Trappers' non-slip foam ... place the fingers in traction. These are ... size. Sold in packages of 5 and ...
... physiological causes of minor knee pain like ... in concert with the motion of the ... and patellar tendon and assisting in the ... plastic support with high density foam padding ...
Medicine Products: